{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:02:26Z","timestamp":1771646546612,"version":"3.50.1"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T00:00:00Z","timestamp":1486598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61527825"],"award-info":[{"award-number":["61527825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471699"],"award-info":[{"award-number":["81471699"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Province Science and Technology Plan Project","award":["2014B090901060"],"award-info":[{"award-number":["2014B090901060"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61308111"],"award-info":[{"award-number":["61308111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171840","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T19:01:21Z","timestamp":1486666881000},"page":"e0171840","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives"],"prefix":"10.1371","volume":"12","author":[{"given":"Liping","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaina","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,2,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/sj.onc.1209550","article-title":"New therapies for hepatocellular carcinoma","volume":"25","author":"MA Avila","year":"2006","journal-title":"Oncogene"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ccr.2014.04.002","article-title":"SnapShot: Hepatocellular carcinoma","volume":"25","author":"JU Marquardt","year":"2014","journal-title":"Cancer Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11912-010-0094-3","article-title":"Current management of hepatocellular cancer","volume":"12","author":"B Rampone","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","article-title":"Hepatocellular carcinoma: clinical frontiers and perspectives","volume":"63","author":"J Bruix","year":"2014","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.mcna.2009.03.004","article-title":"Current management of hepatocellular carcinoma","volume":"93","author":"M Mendizabal","year":"2009","journal-title":"Med Clin North Am"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijrobp.2012.08.043","article-title":"Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities","volume":"87","author":"J Klein","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.7314\/APJCP.2015.16.9.3595","article-title":"Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma","volume":"16","author":"CH Wang","year":"2015","journal-title":"Asian Pac J Cancer P"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1582-4934.2008.00360.x","article-title":"Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy","volume":"13","author":"T Chen","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1016\/j.febslet.2010.08.014","article-title":"The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells","volume":"584","author":"YY Lu","year":"2010","journal-title":"FEBS Lett"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2010.01.001","article-title":"Dihydroartemisinin inactivates NF-\u03baB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both <italic>in vitro<\/italic> and <italic>in vivo<\/italic>","volume":"293","author":"SJ Wang","year":"2010","journal-title":"Cancer Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s10495-013-0953-0","article-title":"Synergistic induction of apoptosis in A549 cells by dihydroartemisinin and gemcitabine","volume":"19","author":"C Zhao","year":"2014","journal-title":"Apoptosis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10495-015-1132-2","article-title":"Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells","volume":"20","author":"G Qin","year":"2015","journal-title":"Apoptosis"},{"key":"ref13","first-page":"1","article-title":"Combination of rapamycin and resveratrol for treatment of bladder cancer","author":"A Alayev","year":"2016","journal-title":"J Cell Physiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/jcp.24863","article-title":"The synergistic effect of SAHA and parthenolide in MDA-MB231 breast cancer cells","volume":"230","author":"D Carlisi","year":"2015","journal-title":"J Cell Physiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"T Efferth","year":"2007","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/ijc.22804","article-title":"Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/\u03b2-catenin pathway","volume":"121","author":"LN Li","year":"2007","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.cellsig.2014.07.001","article-title":"Potent proapoptotic actions of dihydroartemisinin in gemcitabine-resistant A549 cells","volume":"26","author":"C Zhao","year":"2014","journal-title":"Cell Signal"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.7314\/APJCP.2013.14.9.5243","article-title":"Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines","volume":"14","author":"Y Liu","year":"2013","journal-title":"Asian Pac J Cancer P"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4161\/cbt.9.10.11552","article-title":"Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells","volume":"9","author":"Q He","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"ref20","first-page":"279","article-title":"Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-\u03baB and PI3K\/Akt signaling pathways","volume":"39","author":"O Thanaketpaisarn","year":"2011","journal-title":"Int J Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1734-1140(13)71021-1","article-title":"Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells","volume":"65","author":"GS Wu","year":"2013","journal-title":"Pharmacol Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0024-3205(01)01372-8","article-title":"Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells","volume":"70","author":"NP Singh","year":"2001","journal-title":"Life Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.7314\/APJCP.2013.14.8.4615","article-title":"The synergistic anticancer effect of artesunate combined with allicin in osteosarcoma cell line <italic>in vitro<\/italic> and <italic>in vivo<\/italic>","volume":"14","author":"W Jiang","year":"2013","journal-title":"Asian Pac J Cancer P"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3109\/10428194.2013.829573","article-title":"Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide","volume":"55","author":"Y Li","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2006.01.006","article-title":"Ubiquitous activation of Ras and Jak\/Stat pathways in human HCC","volume":"130","author":"DF Calvisi","year":"2006","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","article-title":"Selective inhibition of Ras-dependent cell growth by farnesylthiosalicylic acid","volume":"270","author":"M Marom","year":"1995","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1357-4310(00)01789-5","article-title":"RAS inhibitors: potential for cancer therapeutics","volume":"6","author":"Y Kloog","year":"2000","journal-title":"Mol Med Today"},{"key":"ref28","first-page":"555","article-title":"The Ras inhibitor s-trans, trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance","volume":"8","author":"M Gana-weisz","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1158\/1535-7163.MCT-08-0488","article-title":"Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats","volume":"7","author":"L Goldberg","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00280-007-0451-6","article-title":"Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice","volume":"61","author":"R Haklai","year":"2008","journal-title":"Cancer Chemoth Pharm"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-256","article-title":"Salirasib inhibits the growth of hepatocarcinoma cell lines <italic>in vitro<\/italic> and tumor growth <italic>in vivo<\/italic> through ras and mTOR inhibition","volume":"9","author":"N Charette","year":"2010","journal-title":"Mol Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/boc.201400087","article-title":"Enhancing FTS (Salirasib) efficiency via combinatorial treatment","volume":"107","author":"E Wolfson","year":"2015","journal-title":"Biol Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s10637-012-9818-6","article-title":"Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer","volume":"30","author":"D Laheru","year":"2012","journal-title":"Invest New Drugs"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1535-7163.MCT-06-0706","article-title":"Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid)","volume":"6","author":"A Zundelevich","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1038\/cddis.2012.200","article-title":"Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms","volume":"4","author":"N Charette","year":"2013","journal-title":"Cell Death Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25367","article-title":"Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy","volume":"128","author":"A Biran","year":"2011","journal-title":"Int J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e51449","DOI":"10.1371\/journal.pone.0051449","article-title":"Synergistic effects of combined Wnt\/KRAS inhibition in colorectal cancer cells","volume":"7","author":"L Mologni","year":"2012","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/jnci\/86.20.1517","article-title":"Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design","volume":"86","author":"TC Chou","year":"1994","journal-title":"J Natl Cancer I"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"TC Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"3","author":"A Perelman","year":"2012","journal-title":"Cell Death Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1053\/gast.2001.24835","article-title":"The bile acid\u2014activated phosphatidylinositol 3-kinase pathway inhibits Fas apoptosis upstream of bid in rodent hepatocytes","volume":"120","author":"Y Takikawa","year":"2001","journal-title":"Gastroenterology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"14716","DOI":"10.1073\/pnas.232177599","article-title":"Confirmation by FRET in individual living cells of the absence of significant amyloid \u03b2-mediated caspase 8 activation","volume":"99","author":"R Onuki","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1083\/jcb.200207111","article-title":"Spatio-temporal activation of caspase revealed by indicator that is insensitive to environmental effects","volume":"160","author":"K Takemoto","year":"2003","journal-title":"J Cell Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.micron.2016.04.005","article-title":"Reliable measurement of the FRET sensitized-quenching transition factor for FRET quantification in living cells","volume":"88","author":"J Zhang","year":"2016","journal-title":"Micron"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/35082594","article-title":"Spatio-temporal images of growth-factor-induced activation of Ras and Rap1","volume":"411","author":"N Mochizuki","year":"2001","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1017\/S1431927612014079","article-title":"Ma-PbFRET: multiple acceptors FRET measurement based on partial acceptor photobleaching","volume":"19","author":"H Yu","year":"2013","journal-title":"Microsc Microanal"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jmi.12189","article-title":"Quantitative FRET measurement using emission-spectral unmixing with independent excitation crosstalk correction","volume":"257","author":"J Zhang","year":"2015","journal-title":"J Microsc"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"G Kroemer","year":"2007","journal-title":"Physiol Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.molcel.2009.09.030","article-title":"Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis","volume":"36","author":"H Kim","year":"2009","journal-title":"Mol Cell"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bbamcr.2010.12.019","article-title":"Molecular biology of Bax and Bak activation and action","volume":"1813","author":"D Westphal","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yexcr.2015.07.004","article-title":"Artesunate induces apoptosis via a ROS-independent and Bax-mediated intrinsic pathway in HepG2 cells","volume":"336","author":"G Qin","year":"2015","journal-title":"Exp Cell Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yexcr.2016.06.012","article-title":"Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells","volume":"347","author":"Y Pang","year":"2016","journal-title":"Exp Cell Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"10082","DOI":"10.3748\/wjg.v20.i29.10082","article-title":"Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression","volume":"20","author":"QY Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"HC Lai","year":"2013","journal-title":"Invest New Drugs"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200210158","article-title":"Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis","volume":"160","author":"SS Metkar","year":"2003","journal-title":"J Cell Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s10495-006-0084-y","article-title":"Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-alpha induced apoptosis","volume":"11","author":"S Yang","year":"2006","journal-title":"Apoptosis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e1919","DOI":"10.1038\/cddis.2015.276","article-title":"Caspase-3 feedback loop enhances Bid-induced AIF\/endoG and Bak activation in Bax and p53-independent manner","volume":"6","author":"W Guo","year":"2015","journal-title":"Cell Death Dis"},{"key":"ref58","first-page":"3062","article-title":"Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells","volume":"61","author":"C Jiang","year":"2001","journal-title":"Cancer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1128\/IAI.01546-07","article-title":"Fas\/CD95-mediated apoptosis of type II cells is blocked by Toxoplasma gondii primarily via interference with the mitochondrial amplification loop","volume":"76","author":"D Hippe","year":"2008","journal-title":"Infect Immun"},{"key":"ref60","first-page":"1325","article-title":"2-Chloro-2&apos;-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop","volume":"32","author":"DM Conrad","year":"2008","journal-title":"Int J Oncol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1074\/jbc.M809392200","article-title":"Cleavage of Bid by executioner caspases mediates feed forward amplification of mitochondrial outer membrane permeabilization during genotoxic stress-induced apoptosis in Jurkat cells","volume":"284","author":"SN Shelton","year":"2009","journal-title":"J Biol Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.cdd.4400629","article-title":"Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis","volume":"7","author":"Q Chen","year":"2000","journal-title":"Cell Death Differ"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1360\/02tb9111","article-title":"Mechanism of mitochondrial respiratory control in caspase-3 induced positive feedback loop in apoptosis","volume":"47","author":"X Tian","year":"2002","journal-title":"Sci Bull"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10495-013-0857-z","article-title":"Artemisinin induces A549 cell apoptosis dominantly via a reactive oxygen species-mediated amplification activation loop among caspase-9, -8 and -3","volume":"18","author":"W Gao","year":"2013","journal-title":"Apoptosis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138945006776359412","article-title":"Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells","volume":"7","author":"T Efferth","year":"2006","journal-title":"Curr Drug Targets"},{"key":"ref66","first-page":"247597","article-title":"Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"MP Crespo-Ortiz","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10495-011-0580-6","article-title":"Interruption of the MEK\/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis <italic>in vitro<\/italic> and <italic>in vivo<\/italic>","volume":"16","author":"N Gao","year":"2011","journal-title":"Apoptosis"},{"key":"ref68","first-page":"469","article-title":"Regulation of cell cycle progression and apoptosis by the Ras\/Raf\/MEK\/ERK pathway (Review)","volume":"22","author":"F Chang","year":"2003","journal-title":"Int J Oncol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1038\/sj.onc.1201455","article-title":"Proliferation of human malignant astrocytomas is dependent on Ras activation","volume":"15","author":"A Guha","year":"1997","journal-title":"Oncogene"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18632\/oncotarget.240","article-title":"Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR inhibitors: rationa and importance to inhibiting these pathways in human health","volume":"2","author":"WH Chappell","year":"2011","journal-title":"Oncotarget"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bcp.2012.02.002","article-title":"Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma <italic>in vitro<\/italic> and <italic>in vivo<\/italic>","volume":"83","author":"CZ Zhang","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental therapy of hepatoma with artemisinin and its derivatives: <italic>in vitro<\/italic> and <italic>in vivo<\/italic> activity, chemosensitization, and mechanisms of action","volume":"14","author":"J Hou","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1002\/jcp.24086","article-title":"Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells","volume":"227","author":"C Zhou","year":"2012","journal-title":"J Cell Physiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:28:40Z","timestamp":1588973320000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171840"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,9]]},"references-count":73,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171840","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,9]]}}}